Crescent Capital BDC (CCAP) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 Aug, 2026Executive summary
Net investment income per share was $0.36 for Q2 2026, down from $0.38–$0.42 in the prior quarter, with net income per share at ($0.09) and NAV per share declining to $17.82 from $18.27, mainly due to unrealized losses on non-accrual investments.
Portfolio remains diversified with 192 companies across 18 industries, valued at $1.57 billion, with over 90% in senior secured first lien and unitranche first lien investments.
Regular Q3 2026 dividend of $0.34 per share and a $0.03 per share special dividend were declared, with additional special dividends scheduled for December 2026.
Portfolio rotation and de-leveraging remain top priorities, supported by a revised fee and dividend framework effective April 1, 2026.
Parent company Sun Life holds about 6% of shares and has invested over $1.5 billion across Crescent strategies since 2021.
Financial highlights
Total investment income for Q2 2026 was $36.3 million, down from $37.9 million in Q1 2026, mainly due to lower dividend income and reduced realization activity.
Net realized and unrealized losses for Q2 2026 were $(16.1)–$(16.3) million, reflecting portfolio depreciation.
Dividend income was $1.2 million, down $1.8 million from the prior quarter due to lower Logan JV distributions.
Investment portfolio at fair value was approximately $1.57 billion as of June 30, 2026.
Total net assets were $656 million as of June 30, 2026.
Outlook and guidance
Special dividends of $0.03 per share to be paid in September and December 2026, following the June payment.
Fee structure enhancements, including permanent reductions in base management and incentive fees, are expected to improve dividend coverage and shareholder alignment.
Expect leverage to return to target range in the second half of the year as portfolio realizations occur.
Market conditions are improving, with better terms in the core and lower middle market and optimism for long-term opportunities.
No supplemental dividend will be paid for the quarter under the current framework.
Latest events from Crescent Capital BDC
- Directors were elected for three-year terms and the auditor was ratified with no shareholder questions.CCAP
AGM 2026 - Net investment income and NAV per share declined, with fee reductions and special dividends announced.CCAP
Q1 2026 - Virtual meeting to elect directors and ratify auditor, with online voting available.CCAP
Proxy filing - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing - Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 2025 - Net investment income per share was $0.46 for Q3 2025, with NAV per share at $19.28.CCAP
Q3 2025 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 2024 - Q2 2024 NII reached $0.59/share, NAV hit $20.30, with strong liquidity and low nonaccruals.CCAP
Q2 2024 - Q4 2024 featured stable NAV, strong liquidity, robust dividends, and a diversified portfolio.CCAP
Q4 2024